Original language | English (US) |
---|---|
Pages (from-to) | 1065-1072 |
Number of pages | 8 |
Journal | Neuromuscular Disorders |
Volume | 27 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2017 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Neurology
- Clinical Neurology
- Genetics(clinical)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Neuromuscular Disorders, Vol. 27, No. 11, 11.2017, p. 1065-1072.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - 230th ENMC International Workshop:: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24–26 February 2017
AU - on behalf of the
AU - IMAGiNe Study Group
AU - Pruppers, Mariëlle H.J.
AU - Merkies, Ingemar S.J.
AU - Lunn, Michael P.T.
AU - Notermans, Nicolette C.
AU - van den Bergh, Peter
AU - Blomkwist-Markens, Patricia
AU - Cornblath, David
AU - D'Sa, Shirley
AU - Faber, Catharina
AU - Goedee, Stephan
AU - Gorson, Ken
AU - Léger, Jean Marc
AU - Lewis, Richard
AU - Lunn, Michael
AU - Mazawey, Lou
AU - Merkies, Ingemar
AU - Nobile-Orazio, Eduardo
AU - Notermans, Nicolette
AU - Padua, Luca
AU - van der Pol, Ludo
AU - Pruppers, Mariëlle
AU - Querol, Louis
AU - Steck, Andreas
AU - Willison, Hugh
N1 - Funding Information: The 230th European Neuromuscular Center (ENMC) international workshop occurred in Naarden, the Netherlands, from February 24th to 26th, 2017. The aims of the workshop were: 1) to create an IgM associated peripheral neuropathy study group and achieve consensus regarding the registration of patients with IgM associated peripheral neuropathy in a patient-based registry, 2) to improve future assessment of patients with IgM associated peripheral neuropathy from hematological markers to clinical trials, and 3) to discuss promising therapies for future clinical trials. Seventeen clinicians and researchers (sixteen neurologists and one hematologist) from nine countries (Belgium, Curaçao, France, Italy, the Netherlands, Spain, Switzerland, the United Kingdom, and the United States of America) were present. A patient with IgM associated peripheral neuropathy, a representative of the GBS/CIDP Foundation International, and a PhD student, who received support from the ENMC Young Scientist Program, also attended. Funding Information: The pharmaceutical company GRIFOLS also contributed financially to this workshop with an unrestricted grant to the ENMC.
PY - 2017/11
Y1 - 2017/11
UR - http://www.scopus.com/inward/record.url?scp=85029523661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029523661&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2017.08.001
DO - 10.1016/j.nmd.2017.08.001
M3 - Article
C2 - 28927829
AN - SCOPUS:85029523661
SN - 0960-8966
VL - 27
SP - 1065
EP - 1072
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 11
ER -